TEL-AVIV, Israel, Feb. 20, 2020 /PRNewswire/ — MedHub develops an advanced AI-based solution for interventional cardiologists. AutocathFFR is the only fully workflow-integrated system that enables cardiologists to take better decisions during the diagnostic procedure by providing them with automated image-based stenosis detection and FFR measurement of each captured stenosis. MedHub successfully completed […]
Coronary/Structural Heart
Moleculin Announces Positive Independent Report of No Cardiotoxicity in Annamycin Phase 1 To Date
Supports Moleculin’s Claim that Annamycin is a “Next Generation” Anthracycline HOUSTON, Feb. 20, 2020 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that it has received an independent assessment of the absence of […]
Ablative Solutions Announces Publication of Data from the Peregrine Post-Market Study in the Journal of the American College of Cardiology: Cardiovascular Interventions
Data Provide Preliminary Evidence of Efficacy of the Investigational Peregrine System Kit SAN JOSE, Calif., Feb. 20, 2020 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches for the treatment of hypertension, today announced that positive six-month results from the Peregrine Post-Market Study demonstrating the safety and efficacy of the company’s CE-marked […]
ProtoKinetix Announces Progress in the use of AAGP® in Cardiovascular Medicine
MARIETTA, Ohio–(BUSINESS WIRE)–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX) announces the progress of screening PKX-001 for cardiometabolic disorders. “Using isolated cardiac cells, we demonstrated that PKX-001 exerts cardioprotective effects in cells that are exposed to stress induced by nutrient overload or cardiotoxic drugs. Specifically, PKX-001 minimized cardiac cell damage […]
The Latest in Pediatric Heart Disease: Benefits of Skin-to-Skin Care, Nurse-Initiated PIV Training and Improving Cholesterol Screening in High-Risk Patients
–CHOP’s Cardiology 2020 Conference Research Highlights– PHILADELPHIA, Feb. 17, 2020 /PRNewswire/ — Experts in pediatric heart disease from across the country shared the latest findings from their research at a large national conference hosted by the Cardiac Center at Children’s Hospital of Philadelphia (CHOP). The 23rd Annual Update on Pediatric and Congenital Cardiovascular Disease, “Vision 20/20: Lessons from […]
Endotronix Announces Enrollment of the First Patients in the PROACTIVE-HF Pivotal Trial
Study to support U.S. FDA approval of the Cordella™ Pulmonary Artery Pressure Sensor System for the treatment of patients with chronic heart failure LISLE, Ill., Feb. 18, 2020 /PRNewswire/ — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), today announced the enrollment of […]
Published Real-World Experience Demonstrates VasQ™ External Support Improves Outcomes When Adopted as the Standard of Care
TEL AVIV, Israel, Feb. 18, 2020 /PRNewswire/ — Dr. Robert Shahverdyan, Head of Vascular Access Center at Asklepios Klinik Barmbek of Hamburg, Germany, has recently published a retrospective analysis of his first 32 consecutive radiocephalic (forearm) VasQ™ External Support procedures in the Journal of Vascular Access. VasQ™ External Support, a Laminate Medical technology, is implanted […]
First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients
Press release Malmö, Sweden February 18, 2020 First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients Acarix AB (publ) today announced the initiation of the randomized, multi-center clinical study FILTER-SCAD to examine the cost effectiveness and safety of adding the CADScor®System as a rule-out test in patients referred with symptoms […]
BioVentrix Announces Gregg Stone, MD, as Co-Principal Investigator for ALIVE Pivotal Trial of Transcatheter Device for Heart Failure
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), today announced that Gregg Stone, MD, of New York’s Mount Sinai Health System has signed on to the pivotal ALIVE Trial of the Revivent TC™ TransCatheter Ventricular Enhancement System as co-principal investigator. Dr. Stone […]
Northwell Receives State Approval to Open Four Cardiac Catheterization Labs
Lenox Health Greenwich Village, Mather and Plainview hospitals join Northern Westchester to offer critical new cardiac services NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Three Northwell Health facilities – Lenox Health Greenwich Village, Mather Hospital in Port Jefferson and Plainview Hospital – have received approval this month from the New York State Health and Health Planning Council to […]



